[144] Apollo Commercial Real Estate Finance, Inc. SEC Filing
Apollo Commercial Real Estate Finance, Inc. (ARI) Form 144 notice shows an intended sale of 52,073 common shares through Morgan Stanley Smith Barney with an aggregate market value of $564,471.32, representing sales to occur on or about 09/15/2025 on the NYSE. The shares were acquired as restricted stock units on 01/27/2023. The filing also discloses a prior 10b5-1 sale by Stuart A. Rothstein on 06/16/2025 of 52,074 shares for gross proceeds of $511,819.72. The filer certifies no undisclosed material adverse information and references a possible 10b5-1 plan.
- Clear disclosure of broker, share count, acquisition date, and sale date
- Shares acquired via RSUs — indicates compensation-related origin rather than opportunistic trading
- Seller represents no undisclosed material information and references 10b5-1 procedures
- Insider sale of 52,073 shares may be perceived negatively by some investors despite limited size
Insights
TL;DR: Insider intends to sell ~52k ARI shares (~$564k), consistent with routine RSU monetization and a prior 10b5-1 sale.
This Form 144 indicates a non-derivative sale of common stock by an insider who received the shares as restricted stock units on 01/27/2023. The planned sale of 52,073 shares for about $564,471 on 09/15/2025 appears similar in size to a June 16, 2025 10b5-1 sale of 52,074 shares generating $511,819.72. Such filings typically reflect scheduled monetization rather than company performance signals. The notice includes the standard representation that no material nonpublic information is known to the seller and references a trading plan.
TL;DR: The filing documents compliant insider sale procedures and disclosure; materiality is limited given size relative to total outstanding shares.
From a governance perspective, the disclosure is complete for a Form 144: broker, share count, acquisition history (RSUs), and prior sales are provided. The seller’s representation about absence of undisclosed material information and the mention of a 10b5-1 plan align with best practices. The number of shares to be sold (52,073) is small relative to the stated outstanding shares (138,943,831), suggesting limited potential market impact.